NewAmsterdam Pharma Company
NAMS
#3689
Rank
NZ$4.94 B
Marketcap
$46.23
Share price
7.69%
Change (1 day)
164.38%
Change (1 year)

NewAmsterdam Pharma Company (NAMS) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$0.87 Million

According to NewAmsterdam Pharma Company's latest financial reports the company's total debt is NZ$0.87 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

NewAmsterdam Pharma Company - Total debt on balance sheet (from 2023 to 2023)

Total debt by year

Year Total debt Change
2023-12-31NZ$0.09 M-55.43%
2022-12-31NZ$0.21 M-30.85%
2021-12-31NZ$0.3 M-98.74%
2020-12-31NZ$24.42 M